Follicular helper T (TFH) cells are recently highlighted as their crucial role for humoral immunity to infection as well as their abnormal control to induce autoimmune disease. During an infection, naïve T cells are differentiating into TFH cells which mediate memory B cells and long-lived plasma cells in germinal center (GC). TFH cells are characterized by their expression of master regulator, Bcl-6, and chemokine receptor, CXCR5, which are essential for the migration of T cells into the B cell follicle. Within the follicle, crosstalk occurs between B cells and TFH cells, leading to class switch recombination and affinity maturation. Various signaling molecules, including cytokines, surface molecules, and transcription factors are involved in TFH cell differentiation. IL-6 and IL-21 cytokine-mediated STAT signaling pathways, including STAT1 and STAT3, are crucial for inducing Bcl-6 expression and TFH cell differentiation. TFH cells express important surface molecules such as ICOS, PD-1, IL-21, BTLA, SAP and CD40L for mediating the interaction between T and B cells. Recently, two types of microRNA (miRNA) were found to be involved in the regulation of TFH cells. The miR-17-92 cluster induces Bcl-6 and TFH cell differentiation, whereas miR-10a negatively regulates Bcl-6 expression in T cells. In addition, follicular regulatory T (TFR) cells are studied as thymus-derived CXCR5 (1) . TFH cells are a distinct subset of T cells by expressing Bcl-6 and are localized to B cell follicle in lymphoid organs with critical roles in the mediation of humoral adaptive immunity (2, 3) . Various cytokines, surface molecules, and transcription factors are reported to be involved in TFH cell differentiation (Fig. 1 ). IL-6 and IL-21 are critical cytokines for TFH cell differ- Figure 1 . Molecular mechanisms of Bcl-6 expression in T cells. Bcl-6, the master regulator of TFH cell differentiation is controlled by a complex signaling pathway. Co-stimulatory molecules such as CD28 and ICOS activate PI3K to induce Bcl-6 expression. PTEN, PHLPP2 inhibit Bcl-6 expression through interfering PI3K signaling and Foxo1 directly inhibits Bcl-6 expression. Various cytokines, such as IL-6, IL-21, IL-12, and IFN-γ induce Bcl-6 expression through JAK-STAT signaling pathway while high level of IL-2 in combination with IL-12 induces T-bet to inhibit Bcl-6. Blimp-1 and Bcl-6 is reciprocally regulating each other to make a decision of effector T cell fate between TFH and non-TFH effector cells. Some miRNA such as miR-17-92 induces Bcl-6 expression by interfering phosphatases, which inhibit PI3K signaling pathway while miR-10a directly inhibits Bcl-6 expression. entiation (4) . Surface molecules, including ICOS, CD40L, PD-1, BTLA, and SAP are also important for TFH cell differentiation and their functions (5) . Inhibiting the interaction between CD40 and CD40L, or deficiency of ICOS or its ligand causes defects in formation of the germinal center (GC) (6) and T FH cell differentiation (7, 8) . In addition, SAP contributes to TFH cell differentiation by maintaining stable T and B cell interaction (6, 9) . Cytokine-and co-stimulatory molecule-mediated signaling pathways are essential for expression of the transcription factor B cell lymphoma-6 (Bcl-6), which is the master regulator of TFH cell differentiation and is inhibited by the antagonizing transcription factor Blimp-1. Expression of Bcl-6 and Blimp-1 is reciprocally regulated during T cell differentiation (1).
Bcl-6-deficient T cells failed to differentiate into TFH cells and the GC responses are hardly developed, demonstrating the absolute requirement for Bcl-6 (2,3). TFH cell differentiation program involves a dramatic change in surface expression of chemokine receptors. Reciprocal up-regulation of CXC-chemokine receptor 5 (CXCR5) and down-regulation of CCR7 enables TFH cells to migrate into B cell follicles by responding to CXCL13, the ligand of CXCR5 (10) (11) (12) . Inside of B cell follicles, TFH cells provide B cell help signals by expressing co-stimulatory molecules and secreting cytokines such as IL-4 and IL-21, which are essential for germinal center B cells to undergo class switch recombination, somatic hyper-mutation, affinity maturation, and differentiation of plasma cells and memory B cells in the GC (13) (14) (15) .
Recently, it was reported that some microRNAs (miRNAs) have a regulatory role in TFH cell differentiation and the GC reaction. The miR-17-92 cluster acts as a positive regulator of TFH cell differentiation via suppression of phosphatases that inhibits ICOS-mediated PI3K signaling pathways (16) . In addition, the miR-17-92 cluster represses the expression of RORα, which induces inappropriate gene expression during TFH cell differentiation (17) . By contrast, miR-10a directly inhibits Bcl-6 expression (18), which strongly indicating that miRNAs are involved in dynamic regulation of TFH differentiation.
If the GC reaction mediated by TFH cells is dysregulated or if autoreactive T and B cells are activated, high levels of autoantibody can be accumulated through abnormal GC formation, which contributes to the development of autoimmune diseases (19) . Thus, TFH cells should be tightly regulated to prevent autoimmunity by limiting germinal center reactions to self antigen (20) . Recently, follicular regulatory T (TFR) cells expressing CXCR5 were demonstrated to limit the GC reaction and reduce antibody production by migrating into B cell follicles (21) . The regulation of germinal center reaction by TFH and TFR cells for normal immunity is summarized as figure  (Fig. 2) .
In this review, we discuss the function of cytokines, transcription factors, and signaling pathways related to the differentiation or characteristics of T FH cells. Additionally, we discuss the role of the GC reaction related to TFH and TFR cells in the maintenance of immune homeostasis and provide both a better understanding of the importance of T FH cells in autoimmunity and their clinical relevance in human autoimmune diseases.
SIGNALING PATHWAYS REQUIRED FOR T FH CELL DIFFERENTIATION ICOS, PI3K, and Foxo1
It has been reported that a strong interaction between the TcR and major histocompatibility complex (MHC) class II molecules triggers TFH cell differentiation, which indicates that a strong TcR signal is essential for TFH cell differentiation (22) . In addition, among surface co-stimulatory molecules being expressed by TFH cells, ICOS is induced when CD4 T cells become activated by recognizing antigen through TcRs, which then interact with ICOS-L that is expressed on B cells (7, 11, 23, 24) . Its binding to the ligand ICOS-L triggers activation signals in a similar way to other members of CD28 family co-stimulatory receptors (25, 26) . ICOS plays a significant role in increasing T cell proliferation and the production of cytokines, including IL-21 and IL-4 (11, 27, 28) .
ICOS-mediated PI3K activation is crucial for TFH cell differentiation, as a point mutation on the cytoplasmic tail of ICOS, where PI3K binds to and activates, led to a severely impaired T FH cell differentiation of CD4 T cells (28) . In contrast, overexpression of ICOS is sufficient to maintain TFH cells in CD28-deficient mice (7). Among PI3K subunit p110γ appears to convey ICOS-mediated T FH cell differentiation signaling pathway, as p110γ deficiency resulted in a defective TFH cell differentiation, further strongly indicating that ICOS and PI3K are important for either differentiation or survival of T FH cells. These results imply that ICOS-mediated PI3K signaling is crucial for the differentiation of TFH cells (25) . Moreover, Heping et al. reported that ICOS signaling is critical for motility of T FH cells into the B cell follicle in a Bcl-6 independent manner (29) .
PI3K signaling pathways following TcR and co-stimulation regulate the phosphorylation of Foxo1 to relocate it from the nucleus to the cytoplasm (30, 31) . A recent study revealed that Foxo1 negatively regulates T cell activation and contributes to T cell tolerance (32) . Foxo1-deficient CD4 T cells contribute to the development of autoimmune phenotypes including increased autoantibody production with reduced Foxp3
＋ regulatory T cell development and function, and augmented generation of TFH cells and GC formation. In addition, the presence of Foxo-binding elements has been identified in the promoter region of Bcl-6 (33), which suggests that Foxo1 might act as a transcriptional repressor of Bcl-6 and, if so, Foxo1 might negatively regulate TFH differentiation. Thus, ICOS and PI3K signaling is crucial for T FH differentiation and Foxo1 could be a regulator of GC reaction.
IL-21, IL-6, and STATs IL-6 and IL-21 are well-known pro-inflammatory cytokines with important roles in Bcl-6 expression and TFH cell differentiation (4). IL-21 induces B cell proliferation and class switch recombination and IL-21R is required for antibody response and GC formation (34) . The IL-6-mediated STAT3 activation is also important for IL-21 expression in human and mouse naïve CD4 T cells upon TcR stimulation (35, 36) . STAT3 is phosphorylated by JAK upon IL-6 stimulation, and activated STAT3 was shown to bind to Bcl-6 in T cells (33) . IL-6 is an important factor for Bcl-6 induction in CD4 T cells during dendritic cell priming stage of CD4 T cell activation (37) . However, other signaling pathways could compensate for IL-6 dependent TFH differentiation pathway, as TFH cells are normally found at the peak of the immune response to infection and immunization (38, 39) . IL-6 signaling is required for IL-21 expression via c-Maf (40) (41) (42) . Once being produced, IL-21 further increases its own production through a positive feedback mechanism (43) . Augmented IL-21 was reported to induce the expression of the master regulator for TFH cell differentiation, Bcl-6 (44), while controversies exist whether IL-21 is a critical factor for Bcl-6 induction in CD4 T cells (37) (38) (39) . At a downstream level, Choi et al. showed that IL-6-mediated STAT1 signaling can also prime T FH cells by compensating for STAT3 and inducing Bcl-6 expression. Another recent study demonstrated that IL-12-mediated STAT4 signaling can induce expression of both Bcl-6 and T-bet, and T-bet inhibits the function of Bcl-6 (45) . The balance between T-bet and Bcl-6 expression might be regulated by IL-2 concentration (33). Furthermore, IFN-γ was accounted to lead to abnormal TFH cell differentiation in the sanroque mouse model (46) . Given that IFN-γ induced Bcl-6 via pSTAT1 which binds to an IRE in an exon of Bcl-6 (47), IFN-γ could function as a positive regulator by directly inducing Bcl-6 expression in CD4 T cells. This supported by recent study by Lee et al., which demonstrated that T cell specific deletion of IFN-γR resulted in decreased T FH cell differentiation in sanroque mice (46) . Further studies are needed to clarify how this complex cytokine network regulates Bcl-6 expression and TFH cell differentiation.
Bcl-6 and Blimp-1
The zinc-finger-containing transcriptional repressor Bcl-6 was originally described as a key molecule in GC formation and B cell response (48, 49) . Bcl-6-deficient mice cannot develop somatic hyper-mutation in B cell, result impaired GC formation (50, 51) . In addition, B cells from these mice do not undergo affinity maturation, somatic hyper-mutation, and class switch recombination of immunoglobulin (49) . Recently, Bcl-6 was identified as a crucial factor for T FH cell differentiation (3). Bcl-6-deficient mice show impaired TFH cell differentiation (2) and non-TFH CD4 T cells do not express increased levels of Bcl-6 (2,52). Bcl-6 directly inhibits a number of transcription factors, including T-bet and RORγt, which are key modulators of differentiation of Th1 and Th17 cells, respectively (3). Bcl-6 also inhibits expression of CCR7 and PSGL-1, which negatively regulate the migration of T cells into B cell follicles (39, 53) . Moreover, Bcl-6 regulates the expression of various T FH cell-related molecules, including ICOS, PD-1, PTLA, CD200, and SAP (23). Turner et al. identified the mouse form of Blimp-1, which is induced by cytokine-mediated B cell differentiation (54) . Recent studies reported that the transcription factor Blimp-1 has an antagonistic role of Bcl-6 (1,52,55) and inhibits TFH cell differentiation (1). Blimp-1 is highly expressed in non-T FH effector T cells such as Th1, Th2, and Th17 cells (1, 52) , whereas Bcl-6 is highly expressed only in TFH cells. Moreover, constitutive expression of Blimp-1 inhibited T FH cell formation (1) and Blimp-1 is important for terminal differentiation of both CD4 A recent study demonstrated Ag-specific antibody production was increased in the mice with Bcl-6-deficient Treg cells (21) . Furthermore, increased levels of high affinity antibody, plasma cells, and memory B cells are found in the mice demonstrating that TFR cells expressing Bcl-6 control the GC reaction including plasma cell production and affinity maturation. By contrast, Blimp-1 down-regulates the number of TFR cells, suggesting that Bcl-6 and Blimp-1 also reciprocally regulate differentiation of T FH and T FR cells to control the GC reaction (1). TFR cells therefore seem to play a crucial role in the maintenance of immune tolerance, preventing autoimmune response by inhibiting the GC reaction and antibody production.
micro RNAs miRNAs are functional single stranded RNAs (ssRNAs), which are encoded endogenously, and are involved in immune cell development and differentiation (64, 65) . Recent study reported that the miR-17-92 cluster was regulated by Bcl-6 in CD4 T cells (3) . T cells overexpressing Bcl-6 demonstrated diminished expression of the miR-17-92 cluster, as do T FH cells, which, suppresses the expression of CXCR5. However, several studies have shown that the miRNA-17-92 cluster induces T FH cell differentiation (16, 17) . T cell specific miR-17-92 transgenic mice demonstrate spontaneous Bcl-6 expression, TFH cell differentiation, and GC formation (16) . In contrast, miR-17-92-deficient mice show impaired T FH cell differentiation during acute and chronic virus infection. The miR-17-92 cluster induces TFH cell differentiation through suppression of PTEN and PHLPP2 expression, which regulate the ICOS-PI3K pathway. The miR-17-92 cluster also directly inhibits expression of RORα, which is involved in gene expression of non-T FH effector T cell differentiation (17) . In addition, miR-10a, which is specifically expressed in Treg cells by TGF-β and retinoic acid, directly suppresses Bcl-6 expression (18) . Some induced-T reg (iT reg ) cells migrate to GC in Peyer's patch and have TFH-like phenotypes. miR-10a expression is down-regulated in these iTreg cells and overexpression of miR-10a significantly inhibits the conversion of iTreg into TFH-like cells. More studies on the role of TFR cells and miRNA in TFH differentiation are needed to improve our understanding on dynamic regulation of germinal center reaction.
T FH CELLS IN AUTOIMMUNE DISEASES
Systemic lupus erythematosus Systemic lupus erythematosus (SLE) is an autoimmune disease with a complex phenotype that includes systemic inflammation, fever, fatigue, and chills (66) . Diagnosis of SLE is very difficult because its phenotype overlaps with other diseases. Recent studies have suggested that the pathogenesis of SLE is profoundly related to T FH cells (44, 67, 68) . Spontaneous GC formation and autoantibody production have been reported in many mouse models of SLE (44, 67) , suggesting that TFH cells might be associated with pathogenesis of SLE. Indeed, recent studies demonstrated that TFH cell differentiation is spontaneously induced in these mouse models (44, 67, 68) . Also, dysregulated TFH cell activity contributes to the pathogenesis of SLE through aberrant GC formation and massive production of autoantibodies, such as anti-dsDNA and ANA. TFH cells induce these phenomena via cytokines and co-stimulatory molecules which stimulate B cells (69, 70 (78) . In this study, they showed that abatacept, a fusion protein composed of the Fc region of IgG and the extracellular domain of CTLA-4 has a role in regulation of TFH cell differentiation in OVA-induced RA mouse models. In human RA patients, up-regulated IL-21 level was reported with increased TFH-like cells that enhanced IL-21R expression (79) . This increased TFH-like cells population correlated with enhanced 28-joint count disease activity score and anti-CCP antibody, which indicate disease severity. Synthetically, TFH cells seem to be involved in the pathogenesis of human autoimmune diseases such as SLE, RA, etc., therefore, regulation of TFH cell differentiation could be an important strategy for the suppression of autoimmune diseases.
CONCLUSION
Recently, characterization of TFH cells and germinal center reaction has been highlighted in immunology field that TFH cells have crucial roles in B cell response in adaptive immunity. IL-6 and IL-21 signaling induce expression of CXCR5, which enables the migration of T cells into B cell follicles with expressing Bcl-6, a master transcription factor for T FH cell differentiation. These characteristics of TFH cells distinguish them from other helper T cells. TFH cells can induce affinity maturation, somatic hyper-mutation which mediate memory B cells and long-lived plasma cells with increased germinal centers. However, abnormally activated TFH cell function give rise to an immune reaction against auto-antigens, and subsequently could trigger autoimmune diseases such as SLE, RA, etc. There are several ways including miRNAs, TFR cells, and IL-21 blockade to potentially correct abnormal germinal center reaction by negatively regulating aberrant TFH cell differentiation. Through better understanding of current knowledge of T FH cell mediated dynamic germinal center reaction, we hope to discover novel therapeutic approaches by targeting TFH cells in human autoimmune diseases.
